Works matching IS 02694727 AND DT 2022 AND VI 47 AND IP 1
Results: 21
Omicron variant as nature's solution to the COVID‐19 pandemic.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 3, doi. 10.1111/jcpt.13614
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. i, doi. 10.1111/jcpt.13436
- Publication type:
- Article
Journal of clinical pharmacy and therapeutics—Passing on the baton.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 2, doi. 10.1111/jcpt.13613
- By:
- Publication type:
- Article
Start a New Journey for Journal of Clinical Pharmacy and Therapeutics.
- Published in:
- 2022
- Publication type:
- Editorial
Impact of the National Centralized Drug Procurement Policy (4 + 7 policy) on the drug expenditures of patients treated in outpatient and emergency departments in a large tertiary level‐A hospital in China: A single centre, interrupted time series.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 104, doi. 10.1111/jcpt.13551
- By:
- Publication type:
- Article
Impact of antibiotic prophylaxis courses on postoperative complications following total joint arthroplasty: Finding from Chinese population.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 61, doi. 10.1111/jcpt.13545
- By:
- Publication type:
- Article
Angiotensin‐converting enzyme inhibitors versus angiotensin receptor blockers: New‐onset diabetes mellitus stratified by statin use.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 97, doi. 10.1111/jcpt.13544
- By:
- Publication type:
- Article
Angiotensin II receptor blocker and statin combination therapy associated with higher skeletal muscle index in patients with cardiovascular disease: A retrospective study.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 89, doi. 10.1111/jcpt.13540
- By:
- Publication type:
- Article
Detecting drug‐drug interactions that increase the incidence of long QT syndrome using a spontaneous reporting system.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 70, doi. 10.1111/jcpt.13539
- By:
- Publication type:
- Article
A drug utilization study of oral anticoagulants in five representative cities of China between 2015 and 2019.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 38, doi. 10.1111/jcpt.13538
- By:
- Publication type:
- Article
Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin‐induced thrombocytopenia.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 112, doi. 10.1111/jcpt.13537
- By:
- Publication type:
- Article
Behavioural activation and trial‐based cognitive therapy may be beneficial to reduce suicidal ideation in major depressive disorder: A post hoc study from a clinical trial.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 46, doi. 10.1111/jcpt.13535
- By:
- Publication type:
- Article
Efficacy and safety of remimazolam tosylate in hysteroscopy: A randomized, single‐blind, parallel controlled trial.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 55, doi. 10.1111/jcpt.13525
- By:
- Publication type:
- Article
Association of sunitinib concentration and clinical outcome in patients with metastatic renal cell carcinoma treated with a 2‐week‐on and 1‐week‐off schedule.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 81, doi. 10.1111/jcpt.13517
- By:
- Publication type:
- Article
Advances in targeted therapy in non‐small cell lung cancer with actionable mutations and leptomeningeal metastasis.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 24, doi. 10.1111/jcpt.13489
- By:
- Publication type:
- Article
"Real‐world" effectiveness of methylphenidate in improving the academic achievement of Attention‐Deficit Hyperactivity Disorder diagnosed students—A systematic review.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 6, doi. 10.1111/jcpt.13486
- By:
- Publication type:
- Article
Assessing the ability of boys with Duchenne muscular dystrophy age 4–7 years to swallow softgel capsules: Clinical trial experience with edasalonexent.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 33, doi. 10.1111/jcpt.13478
- By:
- Publication type:
- Article
A role for nebulized tranexamic acid in veno‐venous ECMO patients.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 125, doi. 10.1111/jcpt.13463
- By:
- Publication type:
- Article
Combination therapy for disseminated strongyloidiasis with associated vancomycin‐resistant, linezolid‐intermediate Enterococcus faecium meningitis: A case report.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 121, doi. 10.1111/jcpt.13448
- By:
- Publication type:
- Article
Retracted: Calcitonin Gene‐Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. i, doi. 10.1111/jcpt.13445
- By:
- Publication type:
- Article
A case report of topical local anaesthetic cream inducing methaemoglobinaemia with an over‐the‐counter medication.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 1, p. 119, doi. 10.1111/jcpt.13412
- Publication type:
- Article